PL3583103T3 - Wyciągi roślinne wzbogacone w pochodne ipoliamidu jako immunosupresanty do leczenia zaburzeń immunologicznych - Google Patents

Wyciągi roślinne wzbogacone w pochodne ipoliamidu jako immunosupresanty do leczenia zaburzeń immunologicznych

Info

Publication number
PL3583103T3
PL3583103T3 PL18707229.3T PL18707229T PL3583103T3 PL 3583103 T3 PL3583103 T3 PL 3583103T3 PL 18707229 T PL18707229 T PL 18707229T PL 3583103 T3 PL3583103 T3 PL 3583103T3
Authority
PL
Poland
Prior art keywords
immunosuppressants
plant extracts
immunological disorders
extracts enriched
treating immunological
Prior art date
Application number
PL18707229.3T
Other languages
English (en)
Inventor
Cristiano Ruch Werneck GUIMARÃES
Carlos Eduardo VITOR
Lisandra Ravanelli PESSA
Romulo Dragani REIS
Alessandra MASCARELLO
Fernando Henrique De Souza GAMA
Original Assignee
Aché Laboratórios Farmacêuticos S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aché Laboratórios Farmacêuticos S.A. filed Critical Aché Laboratórios Farmacêuticos S.A.
Publication of PL3583103T3 publication Critical patent/PL3583103T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/94—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems condensed with rings other than six-membered or with ring systems containing such rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/42—Separation; Purification; Stabilisation; Use of additives
    • C07C51/47—Separation; Purification; Stabilisation; Use of additives by solid-liquid treatment; by chemisorption
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/42—Unsaturated compounds containing hydroxy or O-metal groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/76—Unsaturated compounds containing keto groups
    • C07C59/90—Unsaturated compounds containing keto groups containing singly bound oxygen-containing groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/76—Unsaturated compounds containing keto groups
    • C07C59/92—Unsaturated compounds containing keto groups containing —CHO groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
    • C07C69/73—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
    • C07C69/738—Esters of keto-carboxylic acids or aldehydo-carboxylic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/74—Esters of carboxylic acids having an esterified carboxyl group bound to a carbon atom of a ring other than a six-membered aromatic ring
    • C07C69/757—Esters of carboxylic acids having an esterified carboxyl group bound to a carbon atom of a ring other than a six-membered aromatic ring having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
    • C07C2601/10—Systems containing only non-condensed rings with a five-membered ring the ring being unsaturated
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
PL18707229.3T 2017-02-17 2018-02-19 Wyciągi roślinne wzbogacone w pochodne ipoliamidu jako immunosupresanty do leczenia zaburzeń immunologicznych PL3583103T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
BR102017003318A BR102017003318A2 (pt) 2017-02-17 2017-02-17 compostos, processo de produção de compostos, extrato enriquecido, frações ativas de extrato enriquecido, processo de produção de extrato enriquecido, método de seleção de biomassa vegetal para produção de extrato enriquecido, composição e uso para tratamento de desordens imunológicas
PCT/BR2018/050037 WO2018148816A2 (en) 2017-02-17 2018-02-19 Compounds, process of production of compounds, enriched extract, enriched extract active fractions, enriched extract process of production, method for selecting vegetal biomass for enriched extract production, composition and use for treatment of immunological disorders

Publications (1)

Publication Number Publication Date
PL3583103T3 true PL3583103T3 (pl) 2022-08-01

Family

ID=61282932

Family Applications (1)

Application Number Title Priority Date Filing Date
PL18707229.3T PL3583103T3 (pl) 2017-02-17 2018-02-19 Wyciągi roślinne wzbogacone w pochodne ipoliamidu jako immunosupresanty do leczenia zaburzeń immunologicznych

Country Status (27)

Country Link
US (1) US20200231561A1 (pl)
EP (2) EP3583103B1 (pl)
JP (2) JP7349362B2 (pl)
KR (1) KR20190121790A (pl)
CN (1) CN110475768B (pl)
AU (2) AU2018221956B2 (pl)
BR (2) BR102017003318A2 (pl)
CA (1) CA3052713A1 (pl)
CL (1) CL2019002309A1 (pl)
CO (1) CO2019008891A2 (pl)
CY (1) CY1125187T1 (pl)
DK (1) DK3583103T3 (pl)
EC (1) ECSP19058322A (pl)
ES (1) ES2909387T3 (pl)
HR (1) HRP20220377T1 (pl)
IL (1) IL268732A (pl)
LT (1) LT3583103T (pl)
MX (2) MX2019009655A (pl)
PE (1) PE20200449A1 (pl)
PL (1) PL3583103T3 (pl)
PT (1) PT3583103T (pl)
RS (1) RS63162B1 (pl)
SA (1) SA519402443B1 (pl)
SG (1) SG11201907375VA (pl)
SI (1) SI3583103T1 (pl)
WO (1) WO2018148816A2 (pl)
ZA (1) ZA201906106B (pl)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115304652A (zh) * 2022-07-25 2022-11-08 福建华闽晟业生物科技有限公司 一种利用巨菌草制备野芝麻新甙的方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3703543A (en) * 1969-11-05 1972-11-21 American Home Prod Hydroxamic acids of alicyclic amino acids
DE3030477C2 (de) * 1980-08-12 1986-10-16 Dr. Willmar Schwabe GmbH & Co, 7500 Karlsruhe Iridoid-Derivate, Verfahren zu ihrer Herstellung und deren Verwendung
JPH0366682A (ja) * 1989-08-04 1991-03-22 Tsumura & Co 新規イリドイド誘導体
AU651849B2 (en) * 1990-10-09 1994-08-04 Tsumura & Co. Iridoid derivatives and their use as medicines
DE19644422C2 (de) * 1996-10-25 2000-06-15 Stefan Schulz Verwendung von Terpenen zur Behandlung von Autoimmunkrankheiten und bei Transplantat-Abstoßungsreaktionen
EP1145709A1 (de) * 2000-04-14 2001-10-17 Laboratoires Serobiologiques Verwendung von Naturstoffen zur Herstellung von kosmetischen Zubereitungen
EP1503773B9 (en) * 2002-05-10 2012-01-25 Council of Scientific and Industrial Research Hepatoprotective activity of 2 -p-hydroxybenzoylmussaenosidic acid
EP1371372A1 (de) * 2002-06-08 2003-12-17 Cognis Iberia, S.L. Verwendung von Wirkstoffgemischen enthaltend Tocopherole und Extrakte des Harpagophytum procumbens zur Herstellung eines Medikamentes gegen rheumatische Arthritis
JP2008024670A (ja) * 2006-07-24 2008-02-07 Daiwa Kagaku Kogyo Kk 害虫駆除剤
BRPI0700767B8 (pt) * 2007-02-15 2021-05-25 Ache Laboratorios Farmaceuticos Sa composição farmacêutica, produto farmaceutico, processo para obtenção de compostos farmaceuticos e uso de tais compostos para o tratamento do vitiligo
CN103120699B (zh) * 2011-11-18 2017-04-19 天津市国际生物医药联合研究院 环烯醚萜类化合物在制备抗sars的药物中的应用
CN103690551A (zh) * 2013-07-18 2014-04-02 江苏大学 猪殃殃中环烯醚萜苷提取物及其提取方法和医药用途
DE102015102020A1 (de) * 2015-02-12 2016-08-18 Renate Wilmanowicz Immunologisch aktives Phyto-Gemisch und seine Anwendung bei der Prävention und in einem Verfahren zur Behandlung von Effloreszenzen

Also Published As

Publication number Publication date
ES2909387T3 (es) 2022-05-06
CO2019008891A2 (es) 2020-01-17
AU2018221956A1 (en) 2019-08-29
SG11201907375VA (en) 2019-09-27
JP7349362B2 (ja) 2023-09-22
MX2019009655A (es) 2020-07-24
CN110475768B (zh) 2023-12-01
ZA201906106B (en) 2020-08-26
WO2018148816A2 (en) 2018-08-23
WO2018148816A4 (en) 2019-01-03
AU2022201835A1 (en) 2022-04-07
BR112019017128A2 (pt) 2020-04-14
US20200231561A1 (en) 2020-07-23
KR20190121790A (ko) 2019-10-28
PT3583103T (pt) 2022-03-25
JP2023061959A (ja) 2023-05-02
PE20200449A1 (es) 2020-02-28
MX2022012282A (es) 2022-10-27
BR102017003318A2 (pt) 2018-10-30
SI3583103T1 (sl) 2022-07-29
CL2019002309A1 (es) 2020-05-29
SA519402443B1 (ar) 2023-02-08
AU2018221956B2 (en) 2022-03-24
EP3583103B1 (en) 2022-01-12
EP4001270A1 (en) 2022-05-25
RS63162B1 (sr) 2022-05-31
WO2018148816A3 (en) 2018-10-18
CA3052713A1 (en) 2018-08-23
CY1125187T1 (el) 2023-06-09
HRP20220377T1 (hr) 2022-07-08
DK3583103T3 (da) 2022-03-14
CN110475768A (zh) 2019-11-19
RU2019129095A3 (pl) 2021-10-27
ECSP19058322A (es) 2019-10-31
LT3583103T (lt) 2022-04-25
JP2020507607A (ja) 2020-03-12
RU2019129095A (ru) 2021-03-17
IL268732A (en) 2019-10-31
EP3583103A2 (en) 2019-12-25

Similar Documents

Publication Publication Date Title
HK1252741A1 (zh) 用於治療神經疾病的組合物和方法
HK1259336A1 (zh) 用於治療骨髓增生性病症的方法
IL255258A0 (en) Formulated complex endophyte preparations and methods for improved plant properties
IL255257A0 (en) Isolated complex endophyte preparations and methods for improved plant properties
HK1256036A1 (zh) 治療骨髓增生性障礙的方法
IL279308A (en) Methods for the treatment of heptidine-mediated disorders
EP3347000A4 (en) METHODS OF TREATING DISORDERS AND SKIN DISORDERS USING HAPTENES
IL262348A (en) Preparations for the treatment of excessive radiation disorders
GB201600631D0 (en) Modified plant
ZA201806106B (en) Topical composition comprising plant extracts
EP3324960A4 (en) METHOD FOR TREATING DISORDER IN CONNECTION WITH ANGIOGENESIS AND NEOVASCULARIZATION
ZA201807858B (en) Plant treatment composition
EP3322406A4 (en) TRANSPARENT METHODS AND COMPOSITIONS FOR THE TREATMENT OF MAMMARY DISEASES
IL259674B (en) Benzofuran derivatives for the treatment of diseases related to the central nervous system and other diseases
EP3262065A4 (en) Methods and compositions for treating dystroglycanopathy disorders
ZA201906106B (en) Plant extracts enriched with ipolamiide derivatives as immunosuppressants for treating immunological disorders
HK1250624A1 (zh) 用於治療心血管障礙的方法
ZA201900434B (en) Plant stimulating concentrate
ZA202002391B (en) Plant treatment
EP3663309C0 (en) STEROID GLYCOSIDES EXTRACTED FROM THE FURCRAEA FOETIDA PLANT FOR THE TREATMENT OF SKIN CONDITIONS
GB201520050D0 (en) Method for the production of hoodia plant extracts
GB202004939D0 (en) Modified plant
GB201521542D0 (en) Methods for the treatment of cardiovascular disorders
GB201513991D0 (en) Methods for the treatment of cardiovascular disorders
GB201513344D0 (en) Methods for the treatment of Cardiovascular disorders